Cargando…

Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era

The #COVID19 pandemic has led to an increase in the use of eHealth for patients with interstitial lung disease. Healthcare providers worldwide are positive towards further implementation of eHealth for research and clinical practice. https://bit.ly/3h2545M

Detalles Bibliográficos
Autores principales:	Nakshbandi, Gizal, Moor, Catharina C., Johannson, Kerri A., Maher, Toby M., Kreuter, Michael, Wijsenbeek, Marlies S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256489/ https://www.ncbi.nlm.nih.gov/pubmed/34471631 http://dx.doi.org/10.1183/23120541.00405-2021

Ejemplares similares

Role of the internet of medical things in care for patients with interstitial lung disease
por: Nakshbandi, Gizal, et al.
Publicado: (2023)

Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE
por: Nakshbandi, Gizal, et al.
Publicado: (2023)

Managing Fatigue in Patients With Interstitial Lung Disease
por: Kahlmann, Vivienne, et al.
Publicado: (2020)

A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022)

Exhaled breath analysis in interstitial lung disease
por: van der Sar, Iris G., et al.
Publicado: (2023)

Editorial: Interstitial Lung Disease Around the World
por: Wijsenbeek, Marlies, et al.
Publicado: (2022)

Feasibility of online home spirometry in systemic sclerosis–associated interstitial lung disease: a pilot study
por: Moor, Catharina C, et al.
Publicado: (2020)

Home monitoring for patients with ILD and the COVID-19 pandemic
por: Nakshbandi, G, et al.
Publicado: (2020)

The world of rare interstitial lung diseases
por: Buschulte, Katharina, et al.
Publicado: (2023)

Home monitoring of lung function, symptoms and quality of life after admission with COVID‐19 infection: The HOMECOMIN' study
por: Nakshbandi, Gizal, et al.
Publicado: (2022)

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives
por: Kreuter, Michael, et al.
Publicado: (2015)

Research highlights from the 2018 ERS International Congress: interstitial lung diseases
por: Alfaro, Tiago M., et al.
Publicado: (2019)

Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis
por: Moor, Catharina C., et al.
Publicado: (2019)

Educational aspects of rare and orphan lung diseases
por: Alfaro, Tiago M., et al.
Publicado: (2021)

Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases
por: Wijsenbeek, Marlies S., et al.
Publicado: (2022)

Diurnal variation in forced vital capacity in patients with fibrotic interstitial lung disease using home spirometry
por: Moor, Catharina C., et al.
Publicado: (2020)

Fatum Inexorabile: Do Monocytes Predict the Fate of Interstitial Lung Abnormalities?
por: Kreuter, Michael, et al.
Publicado: (2022)

Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases
por: Bonella, Francesco, et al.
Publicado: (2022)

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis
por: Moor, Catharina C., et al.
Publicado: (2017)

Patient reported side-effects of prednisone and methotrexate in a real-world sarcoidosis population
por: Kahlmann, Vivienne, et al.
Publicado: (2021)

The Fatigue Severity Scale in Interstitial Lung Disease: An Energizing Endpoint
por: Wong, Alyson W., et al.
Publicado: (2023)

Desquamative interstitial pneumonia: a systematic review of its features and outcomes
por: Hellemons, Merel E., et al.
Publicado: (2020)

Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study
por: Wijsenbeek, Marlies, et al.
Publicado: (2018)

Comprehensive Care for Patients with Sarcoidosis
por: Moor, Catharina C., et al.
Publicado: (2020)

ERS International Congress 2022: highlights from the Interstitial Lung Diseases Assembly
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology
por: van der Sar, Iris G., et al.
Publicado: (2023)

Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial
por: Noth, Imre, et al.
Publicado: (2021)

Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design
por: Santermans, Eva, et al.
Publicado: (2019)

The need for a holistic approach for SSc-ILD – achievements and ambiguity in a devastating disease
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2020)

ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly
por: Guler, Sabina A., et al.
Publicado: (2022)

Sex and gender in interstitial lung diseases
por: Kawano-Dourado, Leticia, et al.
Publicado: (2021)

Where are the gaps in education in the field of rare lung disease? Perspectives from the ERN-LUNG educational programme survey
por: Powell, Pippa, et al.
Publicado: (2019)

Peripheral blood monocyte count and outcomes in patients with interstitial lung disease: a systematic review and meta-analysis
por: Min, Bohyung, et al.
Publicado: (2023)

The use of online visual analogue scales in idiopathic pulmonary fibrosis
por: Moor, Catharina C., et al.
Publicado: (2022)

Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study
por: Wijsenbeek, Marlies S., et al.
Publicado: (2021)

The flare of care for rare: per aspera ad astra for rare lung diseases!
por: Wijsenbeek, Marlies, et al.
Publicado: (2023)

An opinion on the impacts of COVID-19 worldwide
por: Speth, Robert C.
Publicado: (2022)

Readiness of healthcare providers for eHealth: the case from primary healthcare centers in Lebanon
por: Saleh, Shadi, et al.
Publicado: (2016)

Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials
por: Kreuter, Michael, et al.
Publicado: (2020)

Dyspnoea and cough in patients with systemic sclerosis–associated interstitial lung disease in the SENSCIS trial
por: Volkmann, Elizabeth R, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kmbikstdg9g5th7a9v3hp5au2j